Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | DAO | P14920 | 1/20 | 0.36 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.36 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.36 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.36 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.34 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GFER | P55789 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18099187 | 0.97 | NPC1 (0.37) | NPC1MAPTDAOCASP3RAB9A | |
| SCHEMBL20468100 | 0.82 | — | — | |
| SCHEMBL13416013 | 0.82 | APP (0.50) | NPC1MAPTRAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL14540195 | 0.82 | GRM5 (0.44) | NPC1MAPTSMN1; SMN2ALDH1A1L3MBTL1 | |
| SCHEMBL16844619 | 0.79 | PRMT6 (0.33) | NPC1MAPTDAOCASP3RAB9A | |
| SCHEMBL1173602 | 0.79 | PRMT6 (0.33) | NPC1MAPTDAOCASP3RAB9A | |
| SCHEMBL12884263 | 0.79 | CYP1A2 (0.37) | — | |
| SCHEMBL13167628 | 0.79 | APP (0.54) | NPC1MAPTRAB9AALDH1A1GFER | |
| SCHEMBL7580014 | 0.77 | CYP2C19 (0.39) | PRMT6 | |
| SCHEMBL79595 | 0.77 | MAPK14 (0.35) | DAOPRMT6DPP4L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100224869-A1 | ORGANIC SEMICONDUCTOR MATERIAL, ORGANIC SEMICONDUCTOR STRUCTURE AND ORGANIC SEMICONDUCTOR APPARATUS | DAI NIPPON PRINTING CO., LTD. (JP) | 2010-09-09 | — | — | US | disclosed |
| US-20070045613-A1 | Organic semiconductor material, Organic semiconductor structure and Organic semiconductor apparatus | DAI NIPPON PRINTING CO., LTD. (JP) | 2007-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100224869-A1 | ORGANIC SEMICONDUCTOR MATERIAL, ORGANIC SEMICONDUCTOR STRUCTURE AND ORGANIC SEMICONDUCTOR APPARATUS | TST, OSTC, LATS2 | NPC1 1732/4885MAPT 641/4885DAO 2882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.